Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis00:59

Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis

288
Noncompartmental analyses offer an alternative method for describing drug pharmacokinetics without relying on a specific compartmental model. In this approach, the drug's pharmacokinetics are assumed to be linear, with the terminal phase log-linear. This assumption allows for simplified analysis and interpretation of the drug's behavior in the body.
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
288
Model Approaches for Pharmacokinetic Data: Compartment Models01:14

Model Approaches for Pharmacokinetic Data: Compartment Models

496
Compartmental analysis is a widely adopted approach to characterizing drug pharmacokinetics. It uses compartment models that conceptualize the body as a collection of reversibly communicating compartments, each representing a group of tissues exhibiting similar drug distribution characteristics. The movement rate of the drug between these compartments is typically described by first-order kinetics.
Two primary types of compartment models are recognized: mammillary and catenary. The more...
496
Pharmacokinetic Models: Overview01:20

Pharmacokinetic Models: Overview

1.8K
Pharmacokinetic models utilize mathematical analysis to achieve a detailed quantitative understanding of a drug's life cycle within the body. They are instrumental in simulating a drug's pharmacokinetic parameters, predicting drug concentrations over time, optimizing dosage regimens, linking concentrations with pharmacologic activity, and estimating potential toxicity.
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
1.8K
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models01:06

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

218
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
218
Model Approaches for Pharmacokinetic Data: Physiological Models01:15

Model Approaches for Pharmacokinetic Data: Physiological Models

232
Physiological models in pharmacokinetics are instrumental in understanding the distribution and elimination of drugs within the body. These models describe the drug concentration within target organs, influenced by factors such as drug uptake, tissue volume, and blood flow. Drug uptake is governed by the partition coefficient, which signifies the drug concentration ratio in tissue to that in the blood. The blood flow rate to a specific tissue is expressed as Qt, and the rate of change in tissue...
232
Pharmacokinetic Models: Comparison and Selection Criterion01:26

Pharmacokinetic Models: Comparison and Selection Criterion

301
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
301

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Predictive AI in Clinical Pharmacology: A Call to Action to Develop Robust Benchmarking Practices.

CPT: pharmacometrics & systems pharmacology·2025
Same author

Numerical and Experimental Analysis of Drug Inhalation in Realistic Human Upper Airway Model.

Pharmaceuticals (Basel, Switzerland)·2023
Same author

Numerical and Machine Learning Analysis of the Parameters Affecting the Regionally Delivered Nasal Dose of Nano- and Micro-Sized Aerosolized Drugs.

Pharmaceuticals (Basel, Switzerland)·2023
Same author

Machine Learning and Pharmacometrics for Prediction of Pharmacokinetic Data: Differences, Similarities and Challenges Illustrated with Rifampicin.

Pharmaceutics·2022

相关实验视频

Updated: Jan 6, 2026

Author Spotlight: Developing a Simple and Robust Hepatic Model for Pharmacological and Toxicological Applications
07:23

Author Spotlight: Developing a Simple and Robust Hepatic Model for Pharmacological and Toxicological Applications

Published on: October 20, 2023

1.8K

QSP-Copilot:一个人工智能增强平台,用于加速定量系统药理学模型开发.

Anuraag Saini1, Ali Farnoud1

  • 1Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach, Germany.

CPT: pharmacometrics & systems pharmacology
|October 29, 2025
PubMed
概括

人工智能工具QSP-Copilot通过自动化QSP建模来简化药物开发,将开发时间减少40%并提高罕见疾病的透明度.

科学领域:

  • 药理学 药理学是指药理学的学科.
  • 计算生物学 计算生物学
  • 人工智能的人工智能

背景情况:

  • 定量系统药理学 (QSP) 有助于药物开发,但在知识整合,模型构建,验证和可扩展性方面面临挑战.
  • 传统的QSP工作流往往是缓慢的,劳动密集型,缺乏一致的验证,阻碍了高效的应用.

研究的目的:

  • 引入QSP-Copilot,这是一个人工智能增强的解决方案,用于增强QSP建模工作流程.
  • 通过自动化任务,提高可扩展性和透明度来解决传统QSP的局限性.

主要方法:

  • 开发QSP-Copilot,一个使用多代理系统和大型语言模型 (LLM) 的端到端人工智能解决方案.
  • 模块化支持QSP任务,包括项目范围,模型结构,评估和报告.
  • 应用和验证QSP-Copilot在罕见疾病上的应用:血液凝固和高氏病.

主要成果:

  • 通过任务自动化,QSP-Copilot将QSP模型开发时间减少约40%.
  • 获得了高提取精度:血液凝结率为99.1%,高希病为100.0%.
  • 通过QSP-Copilot系统的文档改进了方法透明度,并减少了手动策划的负担.

结论:

关键词:
在 QSP-copilot 中使用 QSP.代理工作流程的工作流程人工智能 (AI) 是一种人工智能.知识整合 知识整合大型语言模型 (LLM)定量系统药理学 (QSP) 是一种罕见的疾病 罕见的疾病

更多相关视频

In Silico Modeling Method for Computational Aquatic Toxicology of Endocrine Disruptors: A Software-Based Approach Using QSAR Toolbox
05:47

In Silico Modeling Method for Computational Aquatic Toxicology of Endocrine Disruptors: A Software-Based Approach Using QSAR Toolbox

Published on: August 28, 2019

14.5K
Pharmacophore Modeling for Targets with Extensive Ligand Libraries: A Case Study on SARS-CoV-2 Mpro
05:50

Pharmacophore Modeling for Targets with Extensive Ligand Libraries: A Case Study on SARS-CoV-2 Mpro

Published on: September 26, 2025

1.3K

相关实验视频

Last Updated: Jan 6, 2026

Author Spotlight: Developing a Simple and Robust Hepatic Model for Pharmacological and Toxicological Applications
07:23

Author Spotlight: Developing a Simple and Robust Hepatic Model for Pharmacological and Toxicological Applications

Published on: October 20, 2023

1.8K
In Silico Modeling Method for Computational Aquatic Toxicology of Endocrine Disruptors: A Software-Based Approach Using QSAR Toolbox
05:47

In Silico Modeling Method for Computational Aquatic Toxicology of Endocrine Disruptors: A Software-Based Approach Using QSAR Toolbox

Published on: August 28, 2019

14.5K
Pharmacophore Modeling for Targets with Extensive Ligand Libraries: A Case Study on SARS-CoV-2 Mpro
05:50

Pharmacophore Modeling for Targets with Extensive Ligand Libraries: A Case Study on SARS-CoV-2 Mpro

Published on: September 26, 2025

1.3K
  • QSP-Copilot显著提高了QSP建模工作流程的效率和透明度.
  • 像QSP-Copilot这样的人工智能增强的工作流对于提高药物开发的可扩展性和影响,特别是对于罕见疾病,至关重要.
  • QSP-Copilot在生物复杂或数据稀疏的领域促进了知识整合和模型构建.